Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Autoimmune Disorders

Free Subscription 26.01.2026 1 Ann Neurol 5 BMC Neurol 2 Curr Opin Immunol 7 Diabetes 5 Intern Med 3 J Autoimmun 6 J Clin Endocrinol Metab 3 J Neuroimmunol 1 J Rheumatol 2 Kidney Int 1 Lancet 4 Mult Scler 3 Neurology 1 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Neurol

1. PISA M, Lockhart A, Angell T, Avery A, et al
   Topographical Variation of Iron-Rimmed Lesions in the Multiple Sclerosis Brain and Spinal Cord: A Neuropathological Study.
   Ann Neurol. 2026 Jan 18. doi: 10.1002/ana.78113.
   PubMed         Abstract available
   
   

   
   BMC Neurol

2. CAO J, Wang S, Gong T, Zheng W, et al
   MR neurography of tibial and common peroneal nerves in patients with Guillain-Barre syndrome and electrophysiological correlation.
   BMC Neurol. 2026 Jan 23. doi: 10.1186/s12883-025-04618.
   PubMed        
   
   
3. LEEUWENBERG KE, van der Molen LH, Boenink M, Richard E, et al
   The evolution of disease criteria in multiple sclerosis: underlying motives and broader implications.
   BMC Neurol. 2026 Jan 23. doi: 10.1186/s12883-026-04641.
   PubMed         Abstract available
   
   
4. KUCUKKAYA B, Kaydirak M
   The effect of multiple sclerosis on functional status and sexual quality of life in female patients with multiple sclerosis.
   BMC Neurol. 2026 Jan 22. doi: 10.1186/s12883-025-04584.
   PubMed        
   
   
5. ABUHAMMAD A, Ayyad M, Albandak M, AbuKhalaf SM, et al
   Double-seronegative myasthenia gravis: clinical characteristics, treatment, and outcomes - a systematic review of case reports and case series.
   BMC Neurol. 2026 Jan 20. doi: 10.1186/s12883-026-04644.
   PubMed        
   
   
6. YIN N, Li C, Zhao J, Cao Y, et al
   Development of a self-management journey map for people with multiple sclerosis: a qualitative study.
   BMC Neurol. 2026 Jan 19. doi: 10.1186/s12883-026-04631.
   PubMed        
   
   

   
   Curr Opin Immunol

7. MEGHASHYAM S, Serajee FJ, Prakash AV, Altinok D, et al
   Primary angiitis of the central nervous system.
   Curr Opin Immunol. 2026;98:102691.
   PubMed         Abstract available
   
   
8. ELSAGHIR A, Witte T
   New autoantibodies in Sjogren's disease.
   Curr Opin Immunol. 2026;99:102722.
   PubMed         Abstract available
   
   

   
   Diabetes

9. JIA X, Zhang C, Waugh K, Miao D, et al
   Identifying Insulin Autoantibodies With Differential Risk in Type 1 Diabetes With a Novel Bridging ELISA.
   Diabetes. 2026 Jan 12:db250696. doi: 10.2337/db25-0696.
   PubMed         Abstract available
   
   
10. PITA-GRISANTI V, Martins Pecanha FL, Louzada RA, Blandino-Rosano M, et al
    Protection Against Type 1 Diabetes Development in Mice With 4E-BP2 Deletion.
    Diabetes. 2025 Nov 14:db250348. doi: 10.2337/db25-0348.
    PubMed         Abstract available
    
    
11. GALDERISI A, Carr ALJ, Taylor P, Bonet J, et al
    Baseline Insulin Secretion Determines Response to Abatacept in Stage 1 Type 1 Diabetes.
    Diabetes. 2025 Nov 14:db250801. doi: 10.2337/db25-0801.
    PubMed         Abstract available
    
    
12. RUCHI FNU, Schiavon M, Pandey A, Dalla Man C, et al
    Postprandial Glucagon Metabolism in Healthy and Type 1 Diabetes.
    Diabetes. 2025 Nov 20:db250587. doi: 10.2337/db25-0587.
    PubMed         Abstract available
    
    
13. WILSON CS, Stocks BT, Falk AC, Moore DJ, et al
    B Lymphocytes Impede Tregs to Erode Islet Tolerance in Type 1 Diabetes.
    Diabetes. 2025 Nov 25:db250241. doi: 10.2337/db25-0241.
    PubMed         Abstract available
    
    
14. ZHAO LP, Papadopoulos GK, Skyler JS, Parikh HM, et al
    Profiling Associations Between IGHG-FCGR Ligand-Receptor Interactions and Disease Progression From Stage 1 and 2 to Stage 3 Type 1 Diabetes.
    Diabetes. 2025 Dec 3:db250610. doi: 10.2337/db25-0610.
    PubMed         Abstract available
    
    
15. TRIOLO TM, Sosenko JM, Cuthbertson D, Oram RA, et al
    Type 2 Diabetes Genetic Risk and Type 1 Diabetes Heterogeneity and Progression.
    Diabetes. 2025 Dec 10:db250711. doi: 10.2337/db25-0711.
    PubMed         Abstract available
    
    

    
    Intern Med

16. MIYAMOTO AT, Kumanogoh A, Nishide M
    Current Overview of Multi-omics Analyses in Microscopic Polyangiitis and Granulomatosis with Polyangiitis.
    Intern Med. 2026;65:226-232.
    PubMed         Abstract available
    
    
17. BERCIANO J
    Hyperacute Guillain-Barre Syndrome: A Pathophysiological Interpretation.
    Intern Med. 2026 Jan 15. doi: 10.2169/internalmedicine.6808.
    PubMed        
    
    
18. ODA N, Kobayashi S, Nakano K
    GAVE in Systemic Sclerosis with Concurrent Autoimmune Gastritis.
    Intern Med. 2026 Jan 15. doi: 10.2169/internalmedicine.6785.
    PubMed        
    
    
19. HIRANO K, Kondo K, Saito T, Takahashi K, et al
    Steroid-Resistant Relapse of Autoimmune Pancreatitis with Marked Main Pancreatic Duct Dilatation Mimicking Multifocal Pancreatic Cancer.
    Intern Med. 2026 Jan 15. doi: 10.2169/internalmedicine.6704.
    PubMed         Abstract available
    
    
20. YASUI S, Nishimura K, Tanimoto Y, Mugitani M, et al
    A Case of Diffuse Large B-cell Lymphoma Presenting with Protein-losing Enteropathy During Treatment for Systemic Lupus Erythematosus.
    Intern Med. 2026 Jan 15. doi: 10.2169/internalmedicine.5934.
    PubMed         Abstract available
    
    

    
    J Autoimmun

21. LEIJDING C, Gastaldello S, Schiffer T, Kaewin S, et al
    Sera from patients with dermatomyositis and antisynthetase syndrome mediate muscle weakness, impair mitochondrial respiration and induce local cytokine production in muscle tissue.
    J Autoimmun. 2026;158:103522.
    PubMed         Abstract available
    
    
22. DESALEGN D, Fischer S, Bedada Y, Freuer D, et al
    Autoimmunity to mental health: Risk of depression in type 1 diabetes and celiac disease patients - A systematic review, meta-analysis, and bias assessment.
    J Autoimmun. 2026;158:103524.
    PubMed         Abstract available
    
    
23. BERETTA L, Chan CWS, Moysidou GS, Nothling DM, et al
    Molecular stratification and transcriptome-guided therapeutics in systemic lupus erythematosus with insufficient treatment response.
    J Autoimmun. 2026;159:103525.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

24. LAHOTI A, Haque MR, Bianco ME, Chaudhary A, et al
    Trends of Diabetes in Youth (TrenDY) during COVID-19 across the United States.
    J Clin Endocrinol Metab. 2025 Jul 14:dgaf395. doi: 10.1210.
    PubMed         Abstract available
    
    
25. PRAHALAD P, Ding VY, Zaharieva DP, Addala A, et al
    Sustained HbA1c Improvements Over 36 Months in Youth in the Teamwork, Targets, Technology, and Tight Control (4T) Study.
    J Clin Endocrinol Metab. 2026;111:418-426.
    PubMed         Abstract available
    
    
26. STECK AK, Parikh HM, Triolo TM, Ferrat L, et al
    Genetic Risk and Transition through Preclinical Stages of Type 1 Diabetes.
    J Clin Endocrinol Metab. 2025 Jul 9:dgaf392. doi: 10.1210.
    PubMed         Abstract available
    
    
27. 
    Correction to: "Impact of Minimal Dose Strategy Before Antithyroid Drug Discontinuation on Relapse Risk in Graves' Disease".
    J Clin Endocrinol Metab. 2026 Jan 22:dgag016. doi: 10.1210.
    PubMed        
    
    
28. STAN MN, Toro-Tobon D
    Graves' Disease: A New Era of Pathophysiology-Guided Therapeutics.
    J Clin Endocrinol Metab. 2026 Jan 13:dgag010. doi: 10.1210.
    PubMed         Abstract available
    
    
29. LEE JE, Chillon TS, Minich WB, Abel BS, et al
    Insulin Receptor Family Autoantibodies in Patients with Type B insulin Resistance.
    J Clin Endocrinol Metab. 2026 Jan 12:dgaf692. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Neuroimmunol

30. SIMONE K, Nathoo N, Hooper A, Aboseif A, et al
    Immature ovarian teratomas in anti-NMDA receptor encephalitis.
    J Neuroimmunol. 2026;412:578850.
    PubMed         Abstract available
    
    
31. MURAKAMI K, Tsujimoto H, Nakayama Y, Takeuchi H, et al
    The activation of classical and/or lectin complement pathway for the pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy.
    J Neuroimmunol. 2026;412:578848.
    PubMed         Abstract available
    
    
32. KIMURA A, Takekoshi A, Miyazaki Y, Oh-Hashi K, et al
    TMEM132A autoimmunity in patients with suspected autoimmune cerebellar ataxia.
    J Neuroimmunol. 2026;413:578867.
    PubMed         Abstract available
    
    

    
    J Rheumatol

33. PLANTINGA LC, Fitzpatrick J, Dey M, Dall'Era M, et al
    Perceived and Objective Physical Function in Two U.S., Population-Based Cohorts of Adults with Systemic Lupus Erythematosus.
    J Rheumatol. 2026 Jan 15:jrheum.2025-0857. doi: 10.3899/jrheum.2025-0857.
    PubMed         Abstract available
    
    

    
    Kidney Int

34. CANNEY M, Shan S, Er L, Billot L, et al
    A secondary analysis of the TESTING trial predicted individual patient response to corticosteroid treatment in IgA nephropathy.
    Kidney Int. 2026 Jan 20:S0085-2538(26)00005-0. doi: 10.1016/j.kint.2025.
    PubMed         Abstract available
    
    
35. LIU X, Wang L, Lin M, Jia N, et al
    Multi-omics analyses reveal the pathogenic role of terminal ileum-derived IgA(+)beta7(+) cells in IgA nephropathy.
    Kidney Int. 2026 Jan 20:S0085-2538(26)00010-4. doi: 10.1016/j.kint.2025.
    PubMed         Abstract available
    
    

    
    Lancet

36. ABIZAID A, Mehran R, Oliva A, Chamie D, et al
    Abluminus DES+ sirolimus-eluting stent versus everolimus-eluting stent in patients with diabetes and coronary artery disease (ABILITY Diabetes Global): results from a multicentre, randomised controlled trial.
    Lancet. 2026 Jan 8:S0140-6736(25)02157-9. doi: 10.1016/S0140-6736(25)02157.
    PubMed         Abstract available
    
    

    
    Mult Scler

37. PRETZSCH R, El Mahdaoui S, Johnson P, Soares MD, et al
    Neurofilament light chain as a surrogate candidate for disease activity in multiple sclerosis (LUMINOUS)-A meta-regression of randomized controlled trials.
    Mult Scler. 2026 Jan 23:13524585251407973. doi: 10.1177/13524585251407973.
    PubMed         Abstract available
    
    
38. KUMARI S, Stephens S, Yoo PY, Arbour-Nicitopoulos KP, et al
    Built-environment correlates of physical activity in youth with multiple sclerosis.
    Mult Scler. 2026 Jan 20:13524585251407505. doi: 10.1177/13524585251407505.
    PubMed         Abstract available
    
    
39. VAN DER WALT A
    Multiple sclerosis controversies: Detecting progressing events in MS clinics in real-time is possible-commentary.
    Mult Scler. 2026 Jan 14:13524585251409579. doi: 10.1177/13524585251409579.
    PubMed        
    
    
40. NESBITT C, Van Der Walt A, Butzkueven H, Rath L, et al
    Violence and multiple sclerosis: Towards an evidence-informed call to action in neurology.
    Mult Scler. 2026 Jan 13:13524585251409580. doi: 10.1177/13524585251409580.
    PubMed         Abstract available
    
    

    
    Neurology

41. TEO KSH, Kwan MYK, Qu D, Lim LHP, et al
    Patient Perspective: Words That Matter: Reflections on a Patient's Experiences With Guillain-Barre Syndrome.
    Neurology. 2026;106:e214685.
    PubMed         Abstract available
    
    
42. LOCKHART A, Pisa M, Drakesmith H, DeLuca GC, et al
    Iron-Rim Lesions in the Optic Chiasm in Multiple Sclerosis: A Neuropathologic Case Series.
    Neurology. 2026;106:e214515.
    PubMed         Abstract available
    
    
43. CAGOL A, Granziera C
    Turning Our Gaze to the Anterior Visual Pathway: Iron Rim Lesions Come Into View in Multiple Sclerosis.
    Neurology. 2026;106:e214590.
    PubMed        
    
    

    
    PLoS One

44. YANG D, Zhang Y, Ji L, Wu J, et al
    The shared biomarkers and molecular mechanisms of systemic lupus erythematosus and type 2 diabetes.
    PLoS One. 2026;21:e0340312.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

45. GERVAIS A, Bastard P, Zhang Q, Jaffar-Bandjee MC, et al
    Type I IFN autoantibodies underlie chikungunya live-attenuated vaccine encephalitis.
    Proc Natl Acad Sci U S A. 2026;123:e2532212123.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum